NCT00489515View on ClinicalTrials.gov

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

June 30, 2009

Study Completion Date

August 31, 2010

Conditions
Colorectal CancerGallbladder CancerGastric CancerPancreatic CancerSmall Intestine Cancer
Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER